CAH

5 Notable Dividend Increases From the Past Week — Including Phillips 66

Five notable income stocks recently announced dividend increases, including Phillips 66 . Here's what you need to know about each dividend stock.

Cardinal Health Inc Stock Craters on Q3 Earnings Miss

Cardinal Health (CAH) stock was nosediving on Thursday after releasing an earnings miss for its fiscal third quarter of 2018.

Metrics for Earnings Visibility Make Cardinal Health (CAH) a Sell

With a $18.8 billion market value, Cardinal Health Inc (NYSE:CAH) ranks in the top 25% of its industry group, Health Care Providers & Services, and in the top decile of sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's current Portfolio Grader ranking places it 72 among the 82 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 674 among the 782 companies in the sector, and number 4,061 in the nearly 5,000 company Portfolio Grader universe.

Earnings Visibility Keep Cardinal Health (CAH) a Sell

Currently, Cardinal Health Inc (NYSE:CAH) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. CAH has maintained this ranking for 7 months.

Earnings Growth Make Cardinal Health (CAH) a Sell

With a $18.4 billion market value, Cardinal Health Inc (NYSE:CAH) ranks in the top 25% of its industry group, Health Care Providers & Services, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's current Portfolio Grader ranking places it 72 among the 82 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 667 among the 781 companies in the sector, and number 4,088 in the nearly 5,000 company Portfolio Grader universe.

Cardinal Health (CAH) a Sell on Flagging Earnings Momentum

Cardinal Health Inc (NYSE:CAH) is one of 82 companies within the Health Care Providers & Services GICS industry group, which is in turn part of the 782 company GICS Health Care sector. CAH's market value is $18.7 billion which places it in the top 25% of its industry group. The stock's Portfolio Grader ranking currently places it 71 among the 82 companies in this industry group, a spot that is well below-average; squarely in the bottom quartile of the sector with a ranking of 672 among the 782 companies in the sector, and number 4,086 in the nearly 5,000 company Portfolio Grader universe.

Earnings Momentum Keep Cardinal Health (CAH) a Sell

Currently, Cardinal Health Inc (NYSE:CAH) has a Sell using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking CAH has had from Portfolio Grader for 7 months.

Cardinal Health (CAH) Upgrade Limited by Sub-Par Quant Score

Cardinal Health Inc (NYSE:CAH) is a $19.6 billion in market value member of the Health Care Providers & Services GICS industry group where the stock's Portfolio Grader ranking currently places it 72 among the 82 companies in this industry group, a spot that is well below-average. CAH is ranked squarely in the bottom quartile of the sector with a ranking of 635 among the 783 companies in the sector and number 3,966 in the 5000 company Portfolio Grader company universe.

Cardinal Health (CAH) Upgrade Limited by Poor Earnings Growth

As one of the 782 companies in the GICS Health Care sector Cardinal Health Inc (NYSE:CAH) is a member of the 82 company Health Care Providers & Services GICS industry group within this sector. CAH has a market value of $21.1 billion which is in the top quarter of its industry group. The stock's current Portfolio Grader ranking places it 72 among the 82 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 624 among the 782 companies in the sector, and number 3,941 in the nearly 5,000 company Portfolio Grader universe.

Industry Group Rank Analysis Makes Cardinal Health (CAH) a Strong Sell

The current recommendation of Strong Sell for Cardinal Health Inc (NYSE:CAH) is the result of using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. CAH has recently seen its Portfolio Grader rating downgraded over the last month from a Sell to a Strong Sell.

Cardinal Health (CAH) Stock Upgraded to Sell

Portfolio Grader currently ranks Cardinal Health Inc (NYSE:CAH) a Sell. The system for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Cardinal Health (CAH) Stock Upgraded to Sell

Portfolio Grader currently ranks Cardinal Health Inc (NYSE:CAH) a Sell. The system for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Why Davita Inc (DVA), Cardinal Health Inc (CAH) and Pioneer Natural Resources (PXD) Are 3 of Today’s Worst Stocks

Pioneer Natural Resources (PXD), Cardinal Health (CAH) and Davita (DVA) shareholders couldn't wait for Wednesday's closing bell to ring.

10 Dividend Stocks Increasing Payouts — AAPL PEP CAH PSX MIC EXPD BAX PFG MAR SEP

Ten notable dividend stocks raised their payouts last week, including Apple (AAPL) and PepsiCo (PEP).

Valeant Pharmaceuticals Intl Inc (VRX) Stock Could More Than Double

Valeant Pharmaceuticals believes it stabilized its business and will be in turnaround mode for years. For once, VRX stock deserves optimism.

7 Blue-Chip Stocks Every Investor Should Own

When people explore blue-chip stocks, they sell themselves short with stodgy, no-growth plays. This crop of blue chips are much better buys.

Why Goldman Sachs Group Inc (GS), Harley-Davidson Inc (HOG) and Cardinal Health Inc (CAH) Are 3 of Today’s Worst Stocks

Cardinal Health (CAH), Harley-Davidson (HOG) and Goldman Sachs (GS) never even had a prayer of making bullish progress on Tuesday.

3 Dividend Aristocrats to Buy for Income and Growth

Dividend Aristocrats have a slight advantage over your standard blue-chip stock, and these three dividend stocks have both income and growth.

10 Health Care Providers & Services Stocks to Sell Now

This week, 10 Health Care Providers & Services stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").